These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 39205367)

  • 1. Predicting brain atrophy and cognitive aging trajectories with baseline subjective cognitive concerns in cognitively normal older adults.
    You M; Lindbergh CA; La Joie R; Paolillo EW; Saloner R; Diaz V; Cotter DL; Walters S; Altendahl M; Staffaroni AM; Kramer JH; Gaynor LS; Casaletto KB
    Neurobiol Aging; 2024 Nov; 143():1-9. PubMed ID: 39205367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain volume change and cognitive trajectories in aging.
    Fletcher E; Gavett B; Harvey D; Farias ST; Olichney J; Beckett L; DeCarli C; Mungas D
    Neuropsychology; 2018 May; 32(4):436-449. PubMed ID: 29494196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's and neurodegenerative disease biomarkers in blood predict brain atrophy and cognitive decline.
    Dark HE; An Y; Duggan MR; Joynes C; Davatzikos C; Erus G; Lewis A; Moghekar AR; Resnick SM; Walker KA
    Alzheimers Res Ther; 2024 Apr; 16(1):94. PubMed ID: 38689358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal brain structure and cognitive changes over 8 years in an East Asian cohort.
    Leong RLF; Lo JC; Sim SKY; Zheng H; Tandi J; Zhou J; Chee MWL
    Neuroimage; 2017 Feb; 147():852-860. PubMed ID: 27742600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The significance of caudate volume for age-related associative memory decline.
    Bauer E; Toepper M; Gebhardt H; Gallhofer B; Sammer G
    Brain Res; 2015 Oct; 1622():137-48. PubMed ID: 26119913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of brain atrophy associated with episodic memory and semantic fluency decline in aging.
    Pelletier A; Bernard C; Dilharreguy B; Helmer C; Le Goff M; Chanraud S; Dartigues JF; Allard M; Amieva H; Catheline GW
    Aging (Albany NY); 2017 Mar; 9(3):741-752. PubMed ID: 28278492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A generalizable data-driven model of atrophy heterogeneity and progression in memory clinic settings.
    Baumeister H; Vogel JW; Insel PS; Kleineidam L; Wolfsgruber S; Stark M; Gellersen HM; Yakupov R; Schmid MC; Lüsebrink F; Brosseron F; Ziegler G; Freiesleben SD; Preis L; Schneider LS; Spruth EJ; Altenstein S; Lohse A; Fliessbach K; Vogt IR; Bartels C; Schott BH; Rostamzadeh A; Glanz W; Incesoy EI; Butryn M; Janowitz D; Rauchmann BS; Kilimann I; Goerss D; Munk MH; Hetzer S; Dechent P; Ewers M; Scheffler K; Wuestefeld A; Strandberg O; van Westen D; Mattsson-Carlgren N; Janelidze S; Stomrud E; Palmqvist S; Spottke A; Laske C; Teipel S; Perneczky R; Buerger K; Schneider A; Priller J; Peters O; Ramirez A; Wiltfang J; Heneka MT; Wagner M; Düzel E; Jessen F; Hansson O; Berron D
    Brain; 2024 Jul; 147(7):2400-2413. PubMed ID: 38654513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive aging is not created equally: differentiating unique cognitive phenotypes in "normal" adults.
    Casaletto KB; Elahi FM; Staffaroni AM; Walters S; Contreras WR; Wolf A; Dubal D; Miller B; Yaffe K; Kramer JH
    Neurobiol Aging; 2019 May; 77():13-19. PubMed ID: 30772736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of gray matter atrophy with age, β-amyloid, and cognition in aging.
    Oh H; Madison C; Villeneuve S; Markley C; Jagust WJ
    Cereb Cortex; 2014 Jun; 24(6):1609-18. PubMed ID: 23389995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amyloid-β, cortical thickness, and subsequent cognitive decline in cognitively normal oldest-old.
    Pelkmans W; Legdeur N; Ten Kate M; Barkhof F; Yaqub MM; Holstege H; van Berckel BNM; Scheltens P; van der Flier WM; Visser PJ; Tijms BM
    Ann Clin Transl Neurol; 2021 Feb; 8(2):348-358. PubMed ID: 33421355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baseline Frontoparietal Gray Matter Volume Predicts Executive Function Performance in Aging and Mild Cognitive Impairment at 24-Month Follow-Up.
    Lee AJ; Stark JH; Hayes SM;
    J Alzheimers Dis; 2024; 100(1):357-374. PubMed ID: 38875035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association Between Anticholinergic Medication Use and Cognition, Brain Metabolism, and Brain Atrophy in Cognitively Normal Older Adults.
    Risacher SL; McDonald BC; Tallman EF; West JD; Farlow MR; Unverzagt FW; Gao S; Boustani M; Crane PK; Petersen RC; Jack CR; Jagust WJ; Aisen PS; Weiner MW; Saykin AJ;
    JAMA Neurol; 2016 Jun; 73(6):721-32. PubMed ID: 27088965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Grey-matter network disintegration as predictor of cognitive and motor function with aging.
    Koini M; Duering M; Gesierich BG; Rombouts SARB; Ropele S; Wagner F; Enzinger C; Schmidt R
    Brain Struct Funct; 2018 Jun; 223(5):2475-2487. PubMed ID: 29511859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of amyloid pathology and neurodegeneration on cognitive change in cognitively normal adults.
    Bilgel M; An Y; Helphrey J; Elkins W; Gomez G; Wong DF; Davatzikos C; Ferrucci L; Resnick SM
    Brain; 2018 Aug; 141(8):2475-2485. PubMed ID: 29901697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations between cognitive and brain volume changes in cognitively normal older adults.
    Armstrong NM; An Y; Shin JJ; Williams OA; Doshi J; Erus G; Davatzikos C; Ferrucci L; Beason-Held LL; Resnick SM
    Neuroimage; 2020 Dec; 223():117289. PubMed ID: 32835822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Joint effects of gray matter atrophy and altered functional connectivity on cognitive deficits in amnestic mild cognitive impairment patients.
    Xie C; Bai F; Yuan B; Yu H; Shi Y; Yuan Y; Wu D; Zhang ZS; Zhang ZJ
    Psychol Med; 2015 Jul; 45(9):1799-810. PubMed ID: 25511078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal Trajectories in Cortical Thickness and Volume Atrophy: Superior Cognitive Performance Does Not Protect Against Brain Atrophy in Older Adults.
    Gardener SL; Weinborn M; Sohrabi HR; Doecke JD; Bourgeat P; Rainey-Smith SR; Shen KK; Fripp J; Taddei K; Maruff P; Salvado O; Savage G; Ames D; Masters CL; Rowe CC; Martins RN;
    J Alzheimers Dis; 2021; 81(3):1039-1052. PubMed ID: 33935071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic Tumor Necrosis Factor-Alpha Trajectories Relate to Brain Health in Typically Aging Older Adults.
    Lindbergh CA; Casaletto KB; Staffaroni AM; Elahi F; Walters SM; You M; Neuhaus J; Rivera Contreras W; Wang P; Karydas A; Brown J; Wolf A; Rosen H; Cobigo Y; Kramer JH
    J Gerontol A Biol Sci Med Sci; 2020 Jul; 75(8):1558-1565. PubMed ID: 31549145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying brain changes related to cognitive aging using VBM and visual rating scales.
    Pergher V; Demaerel P; Soenen O; Saarela C; Tournoy J; Schoenmakers B; Karrasch M; Van Hulle MM
    Neuroimage Clin; 2019; 22():101697. PubMed ID: 30739844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-Sectional Associations Between Cardiac Biomarkers, Cognitive Performance, and Structural Brain Changes Are Modified by Age.
    Veugen MGJ; Henry RMA; Brunner-La Rocca HP; Dagnelie PC; Schram MT; van Agtmaal MJM; van der Kallen CJH; Sep SJS; van Boxtel MPJ; Bekers O; Meex SJR; Jansen JFA; Kroon AA; Stehouwer CDA
    Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1948-1958. PubMed ID: 29954754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.